Several factors are contributing to surging utilization that is driving the value of the pharmaceutical market higher,including an aging population base;growth outcomes data documenting the clinical cost of efficacy of pharmaceutical therapy;accelerating development of new drugs,both branded and generic and direct -to- custumer advertising. My thesis remains that numerous drug therapies will be released over the next few years,which will need to be discovered,developed,manufacutured,packaged,distributed and sold.Therapies will need to be linked to diseases and monitored.Drug benefits will need to be coordinated,and perscriptions claims processed.Information on utilization will need to be aggregated and returned to the manufacturers. SwissINC